These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6259606)
1. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)]. Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606 [TBL] [Abstract][Full Text] [Related]
2. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)]. Dureux JB; Canton P; Roche G; Weber M; Gérard A Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602 [TBL] [Abstract][Full Text] [Related]
3. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli. Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)]. Guibert J; Acar JF; Justin C; Kitzis MD Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607 [TBL] [Abstract][Full Text] [Related]
7. [The use of cefotaxime against infections (author's transl)]. Lepeu G; Bertrand A; Armengaud M; Aubertin J Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600 [TBL] [Abstract][Full Text] [Related]
8. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)]. Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)]. Goulon M; Gajdos P; Pilliot J Nouv Presse Med; 1981 Feb; 10(8):613-6. PubMed ID: 6259604 [TBL] [Abstract][Full Text] [Related]
10. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)]. Aufrant C; Lambert-Zechovsky N; Aujard Y; Bingen E; Blum C; Beaufils F; Mathieu H Nouv Presse Med; 1981 Feb; 10(8):639-46. PubMed ID: 6259610 [TBL] [Abstract][Full Text] [Related]
11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E; J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704 [TBL] [Abstract][Full Text] [Related]
12. [Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)]. Bastin R; Frottier J; Vilde JL; Bure A Nouv Presse Med; 1981 Feb; 10(8):598-600. PubMed ID: 6259601 [TBL] [Abstract][Full Text] [Related]
13. [Cefotaxime in digestive tract infections (author's transl)]. Paris J; Paris JC; Gérard A Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611 [TBL] [Abstract][Full Text] [Related]
14. [The use of tobramycin in severe infections (author's transl)]. Babinet P; Bricaire F; Tancrede C; Goulon M Sem Hop; 1978 Oct 18-25; 54(33-36):1049-54. PubMed ID: 220716 [TBL] [Abstract][Full Text] [Related]
16. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)]. Motin J; Bouletreau P; Auboyer C; Bui-Xuan B; Flandrois JP; Reverdy ME Nouv Presse Med; 1981 Feb; 10(8):617-21. PubMed ID: 6259605 [No Abstract] [Full Text] [Related]
17. Ceftriaxone in the treatment of serious infections, particularly after surgery. Scully BE; Neu HC Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479 [TBL] [Abstract][Full Text] [Related]